Immunotherapy for cancer using Interleukin-2

Immunotherapy for cancer using Interleukin-2

G442/0011 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 45.0MB

Downloadable file size: 5.4MB

Price image Pricing

Please login to use the price calculator


Caption: Immunotherapy for cancer: an autmomated machine adds nutrient medium to cell culture wells containing lymphocytes that have been doped with Interleukin-2 (IL-2). IL-2 is released naturally by certain key cells of the immune system (T- lymphocytes) after they have been activated by foreign antigens - of cancer cells, for instance. IL-2 amplifies the proliferation of other cell types, including lymphokine-activated natural killer (LANAK) cells that attack cancer cells directly. In this technique, blood is removed, doped with IL-2 & cultured in vitro for 3-4 weeks to raise the population of LANAK cells. The product is then re-injected into the patient. Photographed at Institut Gustave Roussy, Villejuif, France, 1989.

Release details: Model release not required. Property release not required.

Keywords: biological, biology, cell, cells, culture, cultured, immunotherapy, interleukin-2, lanak cell culture, lanak cells, lanak culture, lanak interleukin-2, microbiology

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.